Neurocrine Biosciences (NBIX) Cash & Current Investments (2009 - 2026)
Neurocrine Biosciences (NBIX) reported Cash & Current Investments of $737.9 million for Q3 2026, down 33.8% from $1.11 billion a year earlier but up 89.3% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences posted Cash & Current Investments of $1.48 billion, up 37.6% from FY2024.
- Cash & Current Investments has increased for four consecutive years, with a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $1.08 billion in FY2024 (+3.5%), $1.04 billion in FY2023 (+4.3%), $997.1 million in FY2022 (+39.6%) and $714.5 million in FY2021 (-11.2%).
- Five-year quarterly Cash & Current Investments spans a low of $389.8 million in Q2 2026 and a high of $1.48 billion in Q4 2025.
- Year over year, Cash & Current Investments gained in three of the last eight quarters, with an average decline of 6.3%.
- The high point for year-over-year Cash & Current Investments in five years was Q2 2023 (growth of 50.7%); the low point was Q2 2026 (a decline of 60.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $389.8 million (Q2 2026), $1.32 billion (Q1 2026) and $1.48 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 737.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 737.90 Mn |
| Jun 30, 2026 | 389.80 Mn |
| Mar 31, 2026 | 1.32 Bn |
| Dec 31, 2025 | 1.48 Bn |
| Sep 30, 2025 | 1.11 Bn |
| Jun 30, 2025 | 975.60 Mn |
| Mar 31, 2025 | 943.50 Mn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 1.10 Bn |
| Jun 30, 2023 | 976.70 Mn |
| Mar 31, 2023 | 894.60 Mn |
| Dec 31, 2022 | 997.10 Mn |
| Sep 30, 2022 | 799.40 Mn |
| Jun 30, 2022 | 648.30 Mn |
| Mar 31, 2022 | 664.90 Mn |
| Dec 31, 2021 | 714.50 Mn |
API Access
Neurocrine Biosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();